|

Mid-afternoon market update: Dow jumps over 200 points, Tempur Sealy shares spike higher

Toward the end of trading Thursday, the Dow traded up 0.62% to 35,149.19 while the NASDAQ rose 0.31% to 14,808.82. The S&P also rose, gaining 0.61% to 4,427.67.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 34,675,350 cases with around 611,800 deaths. India confirmed a total of at least 31,528,110 cases and 422,660 deaths, while Brazil reported over 19,797,080 COVID-19 cases with 553,160 deaths. In total, there were at least 196,040,880 cases of COVID-19 worldwide with more than 4,188,530 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Financials shares climbed 1.4% on Thursday. Meanwhile, top gainers in the sector included LendingClub Corporation LC 47.75%, up 54% and AGM Group Holdings Inc. AGMH 8.64% up 7%.

In trading on Thursday, communication services shares fell 0.7%.

Top Headline

Mastercard Incorporated MA 1.42% reported better-than-expected results for its second quarter.

Mastercard reported quarterly adjusted earnings of $1.95 per share, beating analysts’ estimates of $1.72 per share. The company’s revenue came in at $4.50 billion, versus expectations of $4.34 billion.

Equities Trading UP

LendingClub Corporation LC 47.75% shares shot up 54% to $24.99 after the company reported better-than-expected Q2 results and raised guidance.

Shares of NanoVibronix, Inc. NAOV 26.18% got a boost, shooting 27% to $2.42 after the company announced it received registration approval for UroShield from TGA Australia.

Tempur Sealy International, Inc. TPX 15.52% shares were also up, gaining 17% to $43.94 after the company posted upbeat Q2 results and issued strong FY21 earnings forecast.

Equities Trading DOWN

Annovis Bio, Inc. ANVS 61.03% shares tumbled 60% to $44.01 after the company presented new clinical and biomarker data at the 2021 Alzheimer's Association International Conference.

Shares of Atreca, Inc. BCEL 40.19% were down 38% to $5.08 after the company announced initial data from the dose escalation portion of its ongoing Phase 1b trial evaluating ATRC-101 in select solid tumor types, showing the investigational asset was well-tolerated. Preliminary biomarker data supported the proposed mechanism of action found in preclinical studies.

Brightcove Inc. BCOV 14.06% was down, falling 15% to $11.16 after the company issued weak Q3 2021 and FY21 revenue guidance.

Commodities

In commodity news, oil traded up 1.3% to $73.31, while gold traded up 1.7% to $1,830.80.

Silver traded up 3.4% Thursday to $25.725 while copper rose 1.1% to $4.5295.

Euro zone

European shares closed higher today. The eurozone’s STOXX 600 rose 0.46%, the Spanish Ibex Index rose 0.6% and the German DAX 30 gained 0.45%. Meanwhile, the London’s FTSE 100 rose 0.88%, French CAC 40 climbed 0.37% and Italy’s FTSE MIB climbed 1.01%.

The consumer confidence indicator in the Eurozone was confirmed at -4.4 in July, while services confidence indicator climbed to 19.3 in July. The industry confidence indicator in the Eurozone increased to 14.6 in July.

Producer prices in Italy surged 9.1% year-over-year in June. Consumer credit in the UK rose by GBP 0.31 billion in June, while UK factories produced 69,097 cars during June. Spain's unemployment rate fell to 15.26% in the second quarter from 15.98% in the prior three-month period, while annual inflation rate increased to 2.9% in July. French industrial producer increased 1.1% in June, while German unemployment rate stood at 3.7% in June.

Economics

The US economy grew an annualized 6.5% on quarter during the second quarter, down from market estimates of 8.5%.

US initial jobless claims fell to 400,000 in the week ending July 24th.

The pending home sales index dropped 1.9% year-over-year for June.

US natural-gas supplies climbed 36 billion cubic feet last week, the Energy Information Administration said.

Author

Benzinga Team

Benzinga's news desk is a dynamic and innovative team that provides real-time, actionable articles that help readers navigate the market.

More from Benzinga Team
Share:

Editor's Picks

EUR/USD remains offered below 1.1800, looks at US data

EUR/USD is still trading on the defensive in the latter part of Thursday’s session, while the US Dollar maintains its bid bias as investors now gear up for Friday’s key release of the PCE data, advanced Q4 GDP prints and flash PMIs.
 

GBP/USD bounces off monthly lows near 1.3430

GBP/USD is sliding in tandem with its risk-sensitive peers, drifting back towards the 1.3430 area, its lowest levels in the month. The move reflects a firmer Greenback, supported by another round of solid US data and a somewhat divided FOMC Minutes.

Gold surrenders some gains, back below $5,000

Gold is giving away part of its earlier gains on Thursday, receding to the sub-$5,000 region per troy ounce. The precious metal is finding support from renewed geopolitical tensions in the Middle East and declining US Treasury yields across the curve in a context of further advance in the Greenback.

XRP edges lower as SG-FORGE integrates EUR stablecoin on XRP Ledger

Ripple’s (XRP) outlook remains weak, as headwinds spark declines toward the $1.40 psychological support at the time of writing on Thursday.

Hawkish Fed minutes and a market finding its footing

It was green across the board for US Stock market indexes at the close on Wednesday, with most S&P 500 names ending higher, adding 38 points (0.6%) to 6,881 overall. At the GICS sector level, energy led gains, followed by technology and consumer discretionary, while utilities and real estate posted the largest losses.

Injective token surges over 13% following the approval of the mainnet upgrade proposal

Injective price rallies over 13% on Thursday after the network confirmed the approval of its IIP-619 proposal. The green light for the mainnet upgrade has boosted traders’ sentiment, as the upgrade aims to scale Injective’s real-time Ethereum Virtual Machine architecture and enhance its capabilities to support next-generation payments.